Cynthia Ceresney Cohen, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 30 Ramland Road, Suite 200a, Orangeburg, NY 10962 Phone: 845-359-0010 Fax: 845-359-3414 |
Jessica Elizabeth Rough, Pediatrics - Developmental – Behavioral Pediatrics Medicare: Medicare Enrolled Practice Location: 30 Ramland Rd S Ste 200a, Orangeburg, NY 10962 Phone: 845-359-0010 Fax: 845-359-3414 |
Kimberly D Kinney, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 30 Ramland Rd S Ste 200a, Orangeburg, NY 10962 Phone: 845-359-0010 Fax: 845-359-3414 |
Philip Newfield, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 30 Ramland Rd, Suite 200a, Orangeburg, NY 10962 Phone: 845-359-0010 Fax: 845-359-3414 |
News Archive
PharmaMar today announced the start of a multicenter, prospective, pivotal study to analyze the efficacy of the antitumoral compound of marine origin, plitidepsin in patients with relapsed and refractory angioimmunoblastic T-cell lymphoma.
Obesity and obstructive sleep apnea (OSA) tend to co-exist and are associated with high blood pressure. The effects of weight loss and continuous positive airway pressure (CPAP), the standard therapy for OSA, on blood pressure have been previously studied individually, but the incremental benefit of combination therapy (weight loss and CPAP therapy) over either therapy alone in obese patients with OSA has been unknown.
The Center for World Health and Medicine, the University of Missouri-St. Louis Medicinal Chemistry Group, and the Institute for One World Health have joined forces "to develop safe and effective anti-diarrhea drugs …
Differences in factors such as income, education and marital status could contribute overwhelmingly to the gap in life expectancy between blacks and whites in the United States, according to one of the first studies to put a number on how much of the divide can be attributed to disparities in socioeconomic characteristics.
By modifying the properties of the common antibiotic gentamicin, researchers at the Technion-Israel Institute of Technology have developed what could become an effective treatment for many human genetic diseases, including cystic fibrosis (CF), Duchenne muscular dystrophy, Usher Syndrome and numerous cancers.
› Verified 8 days ago